Zobrazeno 1 - 10
of 2 160
pro vyhledávání: '"Settore MED/15 - Malattie Del Sangue"'
Autor:
Marco Cioce, Ivan Borrelli, Lorella Cappucciati, Manuela Giori, Giorgia Gobbi, Roberto Lucifora, Patrizia Mabilia, Mauro Marsullo, Chiara Prendin, Letteria Russo, Maria Silvia Zucca, Maurizio Zega, Simona Sica, Andrea Bacigalupo, Valerio De Stefano, Vezio Savoia, Danilo Celli, Paola Garau, Nicola Serra, Stefano Botti
Publikováno v:
Journal of Psychosocial Oncology. :1-17
Autor:
Riccardo Bomben, Francesca Maria Rossi, Filippo Vit, Tamara Bittolo, Antonella Zucchetto, Robel Papotti, Erika Tissino, Federico Pozzo, Massimo Degan, Jerry Polesel, Pietro Bulian, Roberto Marasca, Gianluigi Reda, Luca Laurenti, Jacopo Olivieri, Annalisa Chiarenza, Roberta Laureana, Massimiliano Postorino, Maria Ilaria Del Principe, Antonio Cuneo, Massimo Gentile, Fortunato Morabito, Gilberto Fronza, Agostino Tafuri, Francesco Zaja, Robin Foà, Francesco Di Raimondo, Giovanni Del Poeta, Valter Gattei
Publikováno v:
Leukemia. 37:914-918
Autor:
Jun‐ichi Nishimura, Antoine Soubret, Noriko Arase, Simon Buatois, Masaki Hotta, Jean‐Eric Charoin, Yoshikazu Ito, Sasha Sreckovic, Hiroyuki Takamori, Christoph Bucher, Yasutaka Ueda, Jules Hernández‐Sánchez, Keisuke Gotanda, Gregor Jordan, Kenji Shinomiya, Julia Ramos, Jin Seok Kim, Jens Panse, Régis Peffault de Latour, Alexander Röth, Eiichi Morii, Hubert Schrezenmeier, Yoshitaka Isaka, Simona Sica, Yuzuru Kanakura, Sung‐Soo Yoon, Taroh Kinoshita, Ido Paz‐Priel, Alexandre Sostelly
Publikováno v:
Clinical Pharmacology & Therapeutics. 113:904-915
Drug–target–drug complexes (DTDCs) are phenomena newly observed in patients who switch from the complement component 5 (C5) inhibitor eculizumab to crovalimab, a novel, anti-C5 antibody in development for paroxysmal nocturnal hemoglobinuria (PNH)
Autor:
Sebastian Giebel, Myriam Labopin, Mohamed Houhou, Denis Caillot, Jürgen Finke, Didier Blaise, Nathalie Fegueux, Mark Ethell, Jan J. Cornelissen, Edouard Forcade, Ibrahim Yakoub-Agha, Federico Lussana, Johan Maertens, Jean Henri Bourhis, Pavel Jindra, Norbert Claude Gorin, Arnon Nagler, Mohamad Mohty
Publikováno v:
Bone Marrow Transplantation, 58(4), 393-400. Nature Publishing Group
Allogeneic hematopoietic cell transplantation (allo-HCT) with reduced intensity conditioning (RIC) is an option for elderly patients with acute lymphoblastic leukemia (ALL). We retrospectively compared results of RIC-allo-HCT from either a matched si
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:ii11-ii20
Most invasive fungal infections are opportunistic in nature but the epidemiology is constantly changing, with new risk groups being identified. Neutropenia is a classical risk factor for fungal infections, while critically ill patients in the ICU are
Autor:
Darko Antic, Natasa Milic, Thomas Chatzikonstantinou, Lydia Scarfò, Vladimir Otasevic, Nina Rajovic, David Allsup, Alejandro Alonso Cabrero, Martin Andres, Monica Baile Gonzales, Antonella Capasso, Rosa Collado, Raul Cordoba, Carolina Cuéllar-García, Juan Gonzalo Correa, Lorenzo De Paoli, Maria Rosaria De Paolis, Giovanni Del Poeta, Maria Dimou, Michael Doubek, Maria Efstathopoulou, Shaimaa El-Ashwah, Alicia Enrico, Blanca Espinet, Lucia Farina, Angela Ferrari, Myriam Foglietta, Alberto Lopez-Garcia, José A. García-Marco, Rocío García-Serra, Massimo Gentile, Eva Gimeno, Maria Gomes da Silva, Odit Gutwein, Yervand K. Hakobyan, Yair Herishanu, José Ángel Hernández-Rivas, Tobias Herold, Gilad Itchaki, Ozren Jaksic, Ann Janssens, Olga B. Kalashnikova, Elżbieta Kalicińska, Arnon P. Kater, Sabina Kersting, Maya Koren-Michowitz, Jorge Labrador, Deepesh Lad, Luca Laurenti, Alberto Fresa, Mark-David Levin, Carlota Mayor Bastida, Lara Malerba, Roberto Marasca, Monia Marchetti, Juan Marquet, Biljana Mihaljevic, Ivana Milosevic, Fatima Mirás, Marta Morawska, Marina Motta, Talha Munir, Roberta Murru, Raquel Nunes, Jacopo Olivieri, Miguel Arturo Pavlovsky, Inga Piskunova, Viola Maria Popov, Francesca Maria Quaglia, Giulia Quaresmini, Gianluigi Reda, Gian Matteo Rigolin, Amit Shrestha, Martin Šimkovič, Svetlana Smirnova, Martin Špaček, Paolo Sportoletti, Oana Stanca, Niki Stavroyianni, Doreen Te Raa, Kristina Tomic, Sanne Tonino, Livio Trentin, Ellen Van Der Spek, Michel van Gelder, Marzia Varettoni, Andrea Visentin, Candida Vitale, Vojin Vukovic, Ewa Wasik-Szczepanek, Tomasz Wróbel, Lucrecia Yáñez San Segundo, Mohamed Yassin, Marta Coscia, Alessandro Rambaldi, Emili Montserrat, Robin Foà, Antonio Cuneo, Marc Carrier, Paolo Ghia, Kostas Stamatopoulos
Publikováno v:
Scientia
Journal of Hematology & Oncology, 15(1):116. BioMed Central
JOURNAL OF HEMATOLOGY & ONCOLOGY, 15(1):116. BioMed Central
Antic, Darko; Milic, Natasa; Chatzikonstantinou, Thomas; Scarfò, Lydia; Otasevic, Vladimir; Rajovic, Nina; Allsup, David; Alonso Cabrero, Alejandro; Andres, Martin; Baile Gonzales, Monica; Capasso, Antonella; Collado, Rosa; Cordoba, Raul; Cuéllar-García, Carolina; Correa, Juan Gonzalo; De Paoli, Lorenzo; De Paolis, Maria Rosaria; Del Poeta, Giovanni; Dimou, Maria; Doubek, Michael; ... (2022). Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. Journal of hematology & oncology, 15(1), p. 116. BioMed Central 10.1186/s13045-022-01333-0
J Hematol Oncol . 2022 Aug 26;15(1):116
Journal of Hematology & Oncology, 15(1):116. BioMed Central
JOURNAL OF HEMATOLOGY & ONCOLOGY, 15(1):116. BioMed Central
Antic, Darko; Milic, Natasa; Chatzikonstantinou, Thomas; Scarfò, Lydia; Otasevic, Vladimir; Rajovic, Nina; Allsup, David; Alonso Cabrero, Alejandro; Andres, Martin; Baile Gonzales, Monica; Capasso, Antonella; Collado, Rosa; Cordoba, Raul; Cuéllar-García, Carolina; Correa, Juan Gonzalo; De Paoli, Lorenzo; De Paolis, Maria Rosaria; Del Poeta, Giovanni; Dimou, Maria; Doubek, Michael; ... (2022). Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL. Journal of hematology & oncology, 15(1), p. 116. BioMed Central 10.1186/s13045-022-01333-0
J Hematol Oncol . 2022 Aug 26;15(1):116
Background Patients with chronic lymphocytic leukemia (CLL) may be more susceptible to COVID-19 related poor outcomes, including thrombosis and death, due to the advanced age, the presence of comorbidities, and the disease and treatment-related immun
Autor:
Alessandra Iurlo, Nicole Galli, Cristina Bucelli, Silvia Artuso, Dario Consonni, Daniele Cattaneo
Publikováno v:
British Journal of Haematology. 200:315-322
Autor:
Valerio De Stefano, Alessandra Larocca, Monica Carpenedo, Michele Cavo, Francesco Di Raimondo, Anna Falanga, Massimo Offidani, Maria Teresa Petrucci, Marco Ruggeri, Roberto Mario Santi, Giovanni Barosi
Publikováno v:
Haematologica. 107:2536-2547
The introduction of new therapeutic agents for multiple myeloma (MM), including proteasome inhibitors, immunomodulatory drugs, and monoclonal antibodies, has improved the outcomes of patients but, in parallel, has changed the frequency and epidemiolo
Autor:
Giovanni D’Arena, Alessandro Sgambato, Silvestro Volpe, Giuseppe Coppola, Rachele Amodeo, Virginia Tirino, Fiorella D’Auria, Teodora Statuto, Luciana Valvano, Giuseppe Pietrantuono, Silvia Deaglio, Dimitar Efremov, Luca Laurenti, Antonella Aiello
Publikováno v:
Hematological Oncology. 40:835-842
Measurable residual disease (MRD) has emerged as a relevant parameter of response to therapy in chronic lymphocytic leukemia (CLL). Although several methods have been developed, flow cytometry has emerged as the most useful and standardized approach